Oral compositions at low dosage of cytotoxic proteins

Details Oral compositions at low dosage of cytotoxic proteins Oral compositions at low dosage of cytotoxic proteins

A - Human Necessities

61

K

A61K 38/16 (2006.01) A61K 9/00 (2006.01) A61K 38/17 (2006.01)

Patent

CA 2321717

Pharmaceutical compositions for the oral and sublingual administration containing proteins extractable from mammalian liver. Such proteins include the proteins marked with UK101 and UK114 and described in WO 92/10197 and WO 96/02567 as well as ubiquitin, contained in the UK101 extract.

L'invention porte sur des compositions pharmaceutiques s'administrant par voie orale ou sublinguale et contenant des protéines extraites du foie de mammifères. Lesdites protéines comprennent les protéines UK101 et UK114 décrites dans le WO92/10197 et le WO96/02567, ainsi que de l'ubiquitine contenue dans l'extrait UK101.

Affiliated with

Also associated with

Rating

Oral compositions at low dosage of cytotoxic proteins does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Oral compositions at low dosage of cytotoxic proteins, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Oral compositions at low dosage of cytotoxic proteins will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1364535